首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum
【24h】

Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum

机译:基于香草蛋白的新型双层肉酮的容易合成鉴定了一种诱导细胞凋亡的一种,并在杀灭氯喹氏疟原虫中捕获青蒿素的协同作用

获取原文
获取原文并翻译 | 示例
       

摘要

The inherent affinity of natural compounds for biological receptors has been comprehensively exploited with great success for the development of many drugs, including antimalarials. Here the natural flavoring compound vanillin has been used as an economical precursor for the synthesis of a series of novel bischalcones whosein?vitroantiplasmodial activities have been evaluated against erythrocytic stages ofPlasmodium falciparum.Bischalcones9,11and13showed promising antiplasmodial activity {Chloroquine (CQ) sensitivePf3D7 IC50(μM): 2.0, 1.5 and 2.5 respectively}but only13displayed potent activities also against CQ resistantPfDd2 andPfIndo strains exhibiting resistance indices of 1.4 and 1.5 respectively. IC90(8?μM) of13showed killing activity against ring, trophozoite and schizont stages. Further,13initiated the cascade of reactions that culminates in programmed cell death of parasites including translocation of phosphatidylserine from inner to outer membrane leaflet, loss of mitochondrial membrane potential, activation of caspase like enzyme, DNA fragmentation and chromatin condensation. The combinations of13?+?Artemisinin (ART) exhibited strong synergy (ΣFIC50:0.46 to 0.58) while13?+?CQexhibited mild synergy(ΣFIC50: 0.7 to 0.98) to mild antagonism(ΣFIC50: 1.08 to 1.23) againstPfIndo. In contrast, both combinations showed marked antagonism againstPf3D7(ΣFIC50: 1.33 to 3.34). These features of apoptosis and strong synergy with Artemisinin suggest that bischalcones possess promising antimalarial drug-like properties and may also act as a good partner drugs for artemisinin based combination therapies (ACTs) against Chloroquine resistantP.?falciparum.
机译:对生物受体的天然化合物的固有亲和力得到了全面地利用许多药物的发展,包括抗疟药。这里,天然调味化合物香草蛋白已被用作合成的经济前体,用于合成其蛋白的新蛋白酶的一系列新的Bischalcones,该方法是针对Falciparum的红细胞阶段评估了vitroLishastamodiens .bischalcones9,11111111117.116位有前途的抗蛋白酶活性{氯喹(CQ)敏感性,PF3D7 IC50(μm ):2.0,1.5和2.5分别}但只有13个DQ DQDATANTPFDD2 ANDPFINDO菌株分别展示了1.4和1.5的抵抗力指数。 IC90(8?μm)11113杀死环,滋篷和Schizont阶段的杀死活动。此外,13化的反应级联,其在寄生虫的编程细胞死亡中终止,包括从内膜传单的磷脂酰丝氨酸的易位,线粒体膜电位损失,胱天蛋白酶的激活,如酶,DNA碎片和染色质缩合。 13的组合为13?+ artemisinin(ART)表现出强大的协同作用(ΣFIC50:0.46至0.58),而13?+?CQEXEXBITE温和的协同效作人(ΣFIC50:0.7至0.98)到温和的拮抗作用(ΣFIC50:1.08至1.23)。相比之下,两种组合显示出明显的拮抗作用,禁止抗拮抗作用(ΣFIC50:1.33至3.34)。与青蒿素的细胞凋亡和强烈协同作用的这些特征表明,Bischalcones具有有前途的抗疟药性质,也可作为氟喹蛋白的组合疗法(作用)对氯喹抑菌的良好合作伙伴药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号